Le Lézard
Classified in: Health, Science and technology
Subject: LICENSING AGREEMENTS

VitalHub Announces Expansion Licensing Deal With Liverpool Heart and Chest Hospital NHS Foundation Trust


TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX: VHI) is pleased to announce an expansion licensing agreement of subsidiary Intouch with Health's ("Intouch") patient flow solutions with Liverpool Heart and Chest Hospital NHS Foundation Trust (the "Trust" or "Liverpool"). This contract expands upon the Company's existing relationship with Poole Hospital, and marks the 8th Intouch with Health contract announced this quarter.

Poole Hospital has been a customer of the Company since 2019, and has recently expanded their operations resulting in increased organizational and operational pressures. Having successfully used the Company's products over the past three years, Poole looked to Intouch with Health for a solution to these pressures, culminating in this agreement. This expansion further widens the reach of Intouch's solutions to Bournemouth and Christchurch Hospitals, spanning across the entirety of University Hospitals Dorset NHS Foundation Trust.

Liverpool Heart and Chest Hospital NHS Foundation Trust serves a catchment area of 2.8 million people, spanning Merseyside, Cheshire, North Wales, and the Isle of Man. The Trust sees more than 100,000 outpatients at its hospitals, annually. Liverpool Heart and Chest Hospital NHS Foundation Trust provides specialist services in cardiothoracic surgery, cardiology, and respiratory medicine including adult cystic fibrosis and diagnostic imaging.

Liverpool Heart and Chest Hospital NHS Foundation Trust has licensed a suite of Intouch's patient flow solutions, including the Check-in, Calling, Flow Manager, Mobile, and HL7 Channels software solutions. This licensing agreement is comprised solely of software products, and has an expected deployment time of twelve-weeks. By implementing these programs, the Trust can expect to see improvements in patient experience and clinical efficiency.

"We are delighted to build upon our existing relationship with Poole Hospital, expanding across the Liverpool Heart and Chest Hospital NHS Trust," said Dan Matlow, CEO of VitalHub Corp. "As the 8th Intouch sale announced this quarter, we continue to reinforce our market leadership and penetration across the UK healthcare landscape. With organic growth forming an important part of our overall expansion strategy, we are pleased by our team's continued progress and execution."

ABOUT LIVERPOOL HEART AND CHEST HOSPITAL NHS FOUNDATION TRUST

Liverpool Heart and Chest Hospital NHS Foundation Trust serves a catchment area of 2.8 million people, spanning Merseyside, Cheshire, North Wales, and the Isle of Man. The Trust sees more than 100,000 outpatients at its hospitals, annually. Liverpool Heart and Chest Hospital NHS Foundation Trust provides specialist services in cardiothoracic surgery, cardiology, respiratory medicine including adult cystic fibrosis and diagnostic imaging. The Trust has been rated top in the country for ?overall experience' in the CQC National Inpatient Survey for 9 out of the last 14 years. Liverpool Heart and Chest Hospital NHS Foundation Trust is devoted to providing excellent, compassionate, and safe care to each of its patients, daily.

ABOUT VITALHUB

Software for Health and Human Services providers designed to simplify the user experience & optimize outcomes.

VitalHub provides technology to Health and Human Services providers including; Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. VitalHub solutions span the categories of Electronic Health Record (EHR), Case Management, Care Coordination, Patient Flow & Operational Visibility, and DOCit Mobile Apps.
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, VitalHub serves 275+ clients across Canada, USA, UK, Australia, Qatar, and Latvia. VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the Toronto Stock Exchange (TSX) under the symbol "VHI".

CAUTIONARY STATEMENT

This press release includes forward-looking statements regarding the Corporation and its business, which may include, but is not limited to, statements with respect to the appointment of a new directors. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including risks regarding the technology industry, failure to obtain regulatory or shareholder approvals, market conditions, economic factors, the equity markets generally and risks associated with growth and competition. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Corporation undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

CONTACT INFORMATION
Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
[email protected]



These press releases may also interest you

at 18:15
Well, the benefits from a boost in vitamins are widely known,...

at 18:05
The Canadian Red Cross has launched the Hurricane Fiona in Canada Appeal to support people across eastern Canada who have been impacted by this devastating hurricane. Money raised will enable the Red Cross to carry out relief, recovery, resiliency...

at 07:53
Trulieve Cannabis Corp.   ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the grand opening of its newest West Virginia dispensary in Milton at 5 Perry Morris Square. The Milton...

at 07:43
Trulieve Cannabis Corp.  ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the grand opening of its newest West Virginia dispensary in Belle at 2700 Dupont Ave Suite 9. The Belle...

at 07:00
As Monday September 26 is World Contraception Day, the SOGC wishes to bring your focus on issues still not solved in Canada. Statistics shows that 48% of young women unintentionally become pregnant (1). This means too few women and girls do not know...

23 sep 2022
The "PD-1 And PD-L1 Inhibitors Market by Application (solid tumors and blood-related tumors) and Geography (North America, Europe, Asia, and Rest of World (ROW)) - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. The...



News published on 16 march 2022 at 07:30 and distributed by: